Our experienced research team dedicates to the development of proprietary high-yielding cell clones and optimizing the cell culture process and media formulation. At the current stage, our team has obtained a single-cell derived clone for AAV suspension culture with 30% to 50% improvement in viral titer compared to the conventional HEK293 cells. We will keep progressing on the screening process of a single-cell derived clone with superior performance.